Latest News

Stay up to date with the latest developments in myasthenia gravis research, advocacy, and community support. Explore news, events, and policy updates to stay informed and get involved.

Browse our categories to explore stories relevant to you, and stay connected with the MG community.

All
  • All
  • About MAA News Items
  • Annual Conference News Items
  • Art With Heart News Items
  • Get Involved News Items
  • Health Professionals News Items
  • Living with MG News Items
  • MG Awareness Month News Items
  • Patient Tool Kit
  • Policy Makers News Items
  • Understanding MG News Items
Patient Survey Still Ongoing!

New information about medications that can worsen symptoms in patients suffering from myasthenia gravis (MG) has been published on the MAA website. This list is designed as an aid to assist guiding therapeutic decisions for MG patients and their doctors.

Updated information on drugs to be used with caution with MG

New information about medications that can worsen symptoms in patients suffering from myasthenia gravis (MG) has been published on the MAA website. This list is designed as an aid to assist guiding therapeutic decisions for MG patients and their doctors.

How Active Are You? Seeking People With MG For Study

Researchers at the School of Health and Rehabilitation Sciences (SHRS) at the University of Queensland are seeking individuals with myasthenia gravis to participate in a study investigating levels of physical activity and sitting time and their relationship with fatigue, quality of life and functional mobility.

New MAA Website

The MAA website has been upgraded and it is fantastic. Please do explore all the new features.

Rituximab and the PBS

The MAA has written in detail to Health Minister Hunt drawing to his attention the potential benefits of making Rituximab available via the PBS.

Inform your Federal Member Please!

The letter requesting support in applying for Rituximab treatment in Myasthenia to be included on the PBS has gone to Minister Hunt.

MG Versus Mgen

An unfortunate media release occurred in July this year.

Rituximab Questionnaire

A questionnaire was made available regarding access to this treatment option.